act-of-1933 Archives

Late-Breaking Abstract on LB-100, Lixte Biotechnology–s Protein Phosphatase 2A Inhibitor, in Combination with a PD-1 Inhibitor in an Animal Model to be Presented at the AACR Annual Meeting

EAST SETAUKET, NY -- (Marketwired) -- 03/09/17 -- Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT) announced that…